Maxcyte Stock Price on June 13, 2024

MXCT Stock  USD 3.55  0.03  0.85%   
If you're considering investing in MaxCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of MaxCyte stands at 3.55, as last reported on the 1st of December, with the highest price reaching 3.62 and the lowest price hitting 3.46 during the day. MaxCyte has Sharpe Ratio of -0.0512, which conveys that the firm had a -0.0512% return per unit of risk over the last 3 months. MaxCyte exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MaxCyte's Risk Adjusted Performance of (0.04), mean deviation of 2.48, and Standard Deviation of 3.29 to check out the risk estimate we provide.
  
At this time, MaxCyte's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 281.7 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 222.4 M in 2024. . At this time, MaxCyte's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.20 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.13). MaxCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0512

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMXCT

Estimated Market Risk

 3.27
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.17
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average MaxCyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MaxCyte by adding MaxCyte to a well-diversified portfolio.
Price Book
1.7556
Enterprise Value Ebitda
(11.07)
Price Sales
8.2121
Shares Float
96.5 M
Wall Street Target Price
9.25

MaxCyte Valuation on June 13, 2024

It is possible to determine the worth of MaxCyte on a given historical date. On June 13, 2024 MaxCyte was worth 5.01 at the beginning of the trading date compared to the closed value of 4.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MaxCyte stock. Still, in general, we apply an absolute valuation method to find MaxCyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MaxCyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MaxCyte's related companies.
 Open High Low Close Volume
  4.70    5.21    4.70    5.00    778,523  
06/13/2024
  5.01    5.05    4.86    4.95    276,639  
  4.91    5.06    4.85    4.90    611,371  
Backtest MaxCyte  |  MaxCyte History  |  MaxCyte Valuation   PreviousNext  
Open Value
5.01
4.95
Closing Value
14.82
Upside

MaxCyte Trading Date Momentum on June 13, 2024

On June 14 2024 MaxCyte was traded for  4.90  at the closing time. The top price for the day was 5.06  and the lowest listed price was  4.85 . The trading volume for the day was 611.4 K. The trading history from June 14, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.01% . The trading delta at closing time against the current closing price is 14.14% .

MaxCyte Fundamentals Correlations and Trends

By evaluating MaxCyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MaxCyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MaxCyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About MaxCyte Stock history

MaxCyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MaxCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MaxCyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MaxCyte stock prices may prove useful in developing a viable investing in MaxCyte
Last ReportedProjected for Next Year
Common Stock Shares Outstanding103.3 M66.8 M
Net Loss-21.2 M-22.3 M

MaxCyte Quarterly Net Working Capital

163.37 Million

MaxCyte Stock Technical Analysis

MaxCyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of MaxCyte technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of MaxCyte trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

MaxCyte Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

MaxCyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

MaxCyte December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how MaxCyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MaxCyte shares will generate the highest return on investment. By undertsting and applying MaxCyte stock market strength indicators, traders can identify MaxCyte entry and exit signals to maximize returns

MaxCyte Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for MaxCyte's price direction in advance. Along with the technical and fundamental analysis of MaxCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MaxCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.